DUSP1 and pulmonary fibrosis: As MKP1 expression in lung fibroblasts serves as an antifibrotic brake capable of resolving pulmonary fibrosis, pharmacotherapies that increase its expression or directly inhibit p38α would be predicted to be beneficial.